Receptor for advanced glycation end-products (RAGE) activates divergent signaling pathways to augment neurite outgrowth of adult sensory neurons

[1]  A. Schmidt,et al.  RAGE Deficiency Improves Postinjury Sciatic Nerve Regeneration in Type 1 Diabetic Mice , 2013, Diabetes.

[2]  N. Calcutt,et al.  Ciliary neurotrophic factor activates NF-κB to enhance mitochondrial bioenergetics and prevent neuropathy in sensory neurons of streptozotocin-induced diabetic rodents , 2013, Neuropharmacology.

[3]  M. Sendtner,et al.  Local axonal function of STAT3 rescues axon degeneration in the pmn model of motoneuron disease , 2012, The Journal of cell biology.

[4]  J. Schulz,et al.  Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity , 2012, Neurobiology of Aging.

[5]  J. Milbrandt,et al.  Dual Leucine Zipper Kinase Is Required for Retrograde Injury Signaling and Axonal Regeneration , 2012, Neuron.

[6]  L. Nicholson,et al.  The role of receptor for advanced glycation end products (RAGE) in neuronal differentiation , 2012, Journal of neuroscience research.

[7]  D. Tang,et al.  The Role of Receptor for Advanced Glycation End Products (RAGE) in the Proliferation of Hepatocellular Carcinoma , 2012, International journal of molecular sciences.

[8]  D. Wright,et al.  Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy. , 2012, Translational research : the journal of laboratory and clinical medicine.

[9]  Nathan T. Ross,et al.  A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease. , 2012, The Journal of clinical investigation.

[10]  Y. Pilpel,et al.  Axonal transcription factors signal retrogradely in lesioned peripheral nerve , 2012, The EMBO journal.

[11]  R. Ramasamy,et al.  Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications , 2011, Annals of the New York Academy of Sciences.

[12]  J. Goldberg,et al.  Multiple transcription factor families regulate axon growth and regeneration , 2011, Developmental neurobiology.

[13]  A. Saleh,et al.  Tumor necrosis factor-α elevates neurite outgrowth through an NF-κB-dependent pathway in cultured adult sensory neurons: Diminished expression in diabetes may contribute to sensory neuropathy , 2011, Brain Research.

[14]  Chih-Hsin Tang,et al.  HMGB‐1 induces IL‐6 production in human synovial fibroblasts through c‐Src, Akt and NF‐κB pathways , 2011, Journal of cellular physiology.

[15]  H. Too,et al.  Mitochondrial Localized STAT3 Is Involved in NGF Induced Neurite Outgrowth , 2011, PloS one.

[16]  I. Mook‐Jung,et al.  RAGE: The beneficial and deleterious effects by diverse mechanisms of actions , 2011, Molecules and cells.

[17]  M. Khrestchatisky,et al.  RAGE–TXNIP axis is required for S100B-promoted Schwann cell migration, fibronectin expression and cytokine secretion , 2010, Journal of Cell Science.

[18]  A. Schmidt,et al.  Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling and Up-regulation of Egr-1 in Hypoxic Macrophages* , 2010, The Journal of Biological Chemistry.

[19]  G. McKhann,et al.  RAGE-mediated signaling contributes to intraneuronal transport of amyloid-β and neuronal dysfunction , 2009, Proceedings of the National Academy of Sciences.

[20]  M. Brownlee,et al.  Hyperglycemia-Induced Reactive Oxygen Species Increase Expression of the Receptor for Advanced Glycation End Products (RAGE) and RAGE Ligands , 2009, Diabetes.

[21]  R. Nelson,et al.  The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease. , 2009, Current opinion in investigational drugs.

[22]  G. Glazner,et al.  Nuclear Factor-&kgr;B Activation in Axons and Schwann Cells in Experimental Sciatic Nerve Injury and Its Role in Modulating Axon Regeneration: Studies With Etanercept , 2009, Journal of neuropathology and experimental neurology.

[23]  M. Schmitz,et al.  Phosphorylation of NF‐κB p65 at Ser468 controls its COMMD1‐dependent ubiquitination and target gene‐specific proteasomal elimination , 2009, EMBO reports.

[24]  M. Karin,et al.  Regulation and function of NF-kappaB transcription factors in the immune system. , 2009, Annual review of immunology.

[25]  V. D’Agati,et al.  Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42* , 2008, Journal of Biological Chemistry.

[26]  K. Tracey,et al.  The HMGB1 Receptor RAGE Mediates Ischemic Brain Damage , 2008, The Journal of Neuroscience.

[27]  T. Hamilton,et al.  Interleukin 1α-induced NFκB Activation and Chemokine mRNA Stabilization Diverge at IRAK1* , 2008, Journal of Biological Chemistry.

[28]  Shitao Li,et al.  Receptor for advanced glycation end products (RAGE) mediates neuronal differentiation and neurite outgrowth , 2008, Journal of neuroscience research.

[29]  W. Liu,et al.  Receptor for Advanced Glycation End Products (RAGEs) and Experimental Diabetic Neuropathy , 2008, Diabetes.

[30]  R. Ramasamy,et al.  Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice. , 2008, The Journal of clinical investigation.

[31]  A. Davies,et al.  Nuclear Factor-κB Activation via Tyrosine Phosphorylation of Inhibitor κB-α Is Crucial for Ciliary Neurotrophic Factor-Promoted Neurite Growth from Developing Neurons , 2007, The Journal of Neuroscience.

[32]  Paul J Thornalley,et al.  Advanced glycation endproducts: what is their relevance to diabetic complications? , 2007, Diabetes, obesity & metabolism.

[33]  A. Sastry,et al.  Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. , 2007, Endocrinology.

[34]  W. Snider,et al.  Intracellular control of developmental and regenerative axon growth , 2006, Philosophical Transactions of the Royal Society B: Biological Sciences.

[35]  J. Keller,et al.  Evaluation of rage isoforms, ligands, and signaling in the brain. , 2005, Biochimica et biophysica acta.

[36]  J. Schapansky,et al.  Activation of Nuclear Factor-κB via Endogenous Tumor Necrosis Factor α Regulates Survival of Axotomized Adult Sensory Neurons , 2005, The Journal of Neuroscience.

[37]  A. Verkhratsky,et al.  Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3-kinase in adult sensory neurons , 2005, Molecular and Cellular Neuroscience.

[38]  J. Schneider,et al.  Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. , 2004, The Journal of clinical investigation.

[39]  W. Trojaborg,et al.  RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  W. Trojaborg,et al.  Antagonism of RAGE suppresses peripheral nerve regeneration , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  Xi Chen,et al.  RAGE potentiates Aβ‐induced perturbation of neuronal function in transgenic mice , 2004, The EMBO journal.

[42]  R. Ramasamy,et al.  Protein Glycation: A Firm Link to Endothelial Cell Dysfunction , 2004, Circulation research.

[43]  A. MacLennan,et al.  STAT3 phosphorylation in injured axons before sensory and motor neuron nuclei: Potential role for STAT3 as a retrograde signaling transcription factor , 2004, The Journal of comparative neurology.

[44]  H. Huttunen,et al.  Amphoterin as an extracellular regulator of cell motility: from discovery to disease , 2004, Journal of internal medicine.

[45]  H. Huttunen,et al.  Receptor for Advanced Glycation End Products (RAGE) Signaling Induces CREB-dependent Chromogranin Expression during Neuronal Differentiation* , 2002, The Journal of Biological Chemistry.

[46]  A. Schmidt,et al.  Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: Insights into the pathogenesis of macrovascular complications in diabetes , 2002, Current atherosclerosis reports.

[47]  R. de Caterina,et al.  Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE: A Mechanism for Amplification of Inflammatory Responses , 2002, Circulation.

[48]  M. Andrassy,et al.  Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. , 2001, Diabetes.

[49]  A. Schmidt,et al.  The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. , 2001, The Journal of clinical investigation.

[50]  R. Donato,et al.  S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. , 2001, The international journal of biochemistry & cell biology.

[51]  M. Crow,et al.  Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion. , 2001, Diabetes.

[52]  H. Huttunen,et al.  Coregulation of Neurite Outgrowth and Cell Survival by Amphoterin and S100 Proteins through Receptor for Advanced Glycation End Products (RAGE) Activation* , 2000, The Journal of Biological Chemistry.

[53]  M. Kaksonen,et al.  Heparin-binding proteins HB-GAM (pleiotrophin) and amphoterin in the regulation of cell motility. , 2000, Matrix biology : journal of the International Society for Matrix Biology.

[54]  T. Kislinger,et al.  Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases , 2000, Nature.

[55]  A. Davies,et al.  Cytokine-Induced Nuclear Factor Kappa B Activation Promotes the Survival of Developing Neurons , 2000, The Journal of cell biology.

[56]  H. Huttunen,et al.  Receptor for Advanced Glycation End Products (RAGE)-mediated Neurite Outgrowth and Activation of NF-κB Require the Cytoplasmic Domain of the Receptor but Different Downstream Signaling Pathways* , 1999, The Journal of Biological Chemistry.

[57]  J. Priestley,et al.  Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. , 1999, Diabetes.

[58]  A. Schmidt,et al.  Activation of the Receptor for Advanced Glycation End Products Triggers a p21 ras -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress* , 1997, The Journal of Biological Chemistry.

[59]  Deanna S. Smith,et al.  A Transcription-Dependent Switch Controls Competence of Adult Neurons for Distinct Modes of Axon Growth , 1997, The Journal of Neuroscience.

[60]  J. Chen,et al.  The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin , 1995, The Journal of Biological Chemistry.

[61]  K. O. Elliston,et al.  Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. , 1992, The Journal of biological chemistry.

[62]  小山英則.  9．メタボリックシンドローム/肥満におけるReceptor for Advanced Glycation Endproducts（RAGE）の意義 , 2010 .

[63]  Claus W Heizmann,et al.  Crosstalk Between Calcium, Amyloid β and the Receptor for Advanced Glycation Endproducts in Alzheimer's Disease , 2009, Reviews in the neurosciences.

[64]  Lianyu Shan,et al.  Muscle Cells SmoothCCL 11 Expression in Human Airway Critical Role for STAT 3 in IL-17 A-Mediated , 2009 .

[65]  N. Alkayed,et al.  Role of Signal Transducer and Activator of Transcription 3 in Neuronal Survival and Regeneration , 2008, Reviews in the neurosciences.

[66]  N. Calcutt,et al.  Growth factors as therapeutics for diabetic neuropathy. , 2008, Current drug targets.

[67]  J. Schapansky,et al.  Activation of nuclear factor-kappaB via endogenous tumor necrosis factor alpha regulates survival of axotomized adult sensory neurons. , 2005, The Journal of neuroscience : the official journal of the Society for Neuroscience.